HMGB1 and neoplasm: However, the deletion or mutation of HMGB1 leads to the low expression of MHC class I (MHC-I), which fails to present tumor-derived antigens to CD8+ T cells, resulting in the failure of cytotoxic T cells to effectively recognize and kill tumor cells.